Effects of irbesartan and termisartan on serum levels of uric acid and endothelial function

Effects of irbesartan and termisartan on serum levels of uric acid and endothelial function - Effects of irbesartan and termisartan on serum levels of uric acid and endothelial function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015921

Enrollment

140

Registered

2014-12-12

Start date

2013-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

irbesartan group 4 months irbesartan 100mg/day once every day for 4 months termisartan group 4 months termisartan 40mg/day once every day for 4 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: serum levels of uric acid between 5.0 - 8.0 mg/dl and non user of ARB within 4weeks hypertensive patients

Exclusion criteria

Exclusion criteria: serum creatinine >=1.5 mg/dl history of gout attack

Design outcomes

Primary

Measure	Time frame
Changes in serum level uric acid	—

Secondary

Measure	Time frame
Changes in blood pressure and endothlial function	—

Countries

Japan

Contacts

Public ContactYoshizawa Keiko

Dokkyo Medical University Nikko Medical Center Department of Cardiovascular medicine

kyoshi@dokkyomed.ac.jp0288-76-1515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026